ELAN ELAN エランコ・アニマル・ヘルス

 ELANのチャート


 ELANの企業情報

symbol ELAN
会社名 Elanco Animal Health Inc (ELAN エランコ・アニマル・ヘルス)
分野(sector)   
産業(industry)   
業種 医薬品   医療関連(Health Care)
概要 事業概要 エランコ・アニマル・ヘルス(Elanco Animal Health Incorporated)はコンパニオンとフード・アニマル向け製品を開発、製造、販売する動物健康会社である。同社はコンパニオン・アニマル疾患予防、コンパニオン・アニマル・セラピューティックス、フード・アニマル・フューチャータンパク質・健康、およびフード・アニマル反芻動物・豚などの4種類で製品を提供する。同社は虫、ノミおよびダニからペットを守る製品とともに、徴候、種および製剤に基づいてコンパニオン・アニマル・セクターに各種寄生虫駆除剤ポートフォリオを提供する。同社はまた、種、行動様式、適応症および病期にわたる疼痛および変形性関節症ポートフォリオを提供する。また、耳炎(耳感染症)、心臓血管および皮膚科の適応症も提供する。フード・アニマル・フューチャータンパク質・健康カテゴリーのポートフォリオにはワクチン、栄養酵素、動物専用抗生物質が含まれる。同社はまた、家禽や養殖生産の製品を提供する。  エランコ・アニマル・ヘルスは米国の動物向け医薬品メ―カ―。コンパニオンアニマル、畜産及び水産用の医薬品、ワクチン、飼料用製品の開発・製造・販売を手掛ける。主にペット、魚、肉牛、乳牛、鶏、豚のための寄生虫駆除薬、治療薬食品・補助食品、抗菌剤、衛生製品、飼料添加物、混合飼料などをグロ―バルに提供する。本社所在地はインディアナ州グリ―ンフィ―ルド。  Elanco Animal Health Incorporated is a global leader in animal health dedicated to innovating and delivering products and services to prevent and treat disease in farm animals and pets, creating value for farmers, pet owners, veterinarians, stakeholders, and society as a whole. With nearly 70 years of animal health heritage, it is committed to helping its customers improve the health of animals in their care, while also making a meaningful impact on its local and global communities. It is driven by its vision of Food and Companionship Enriching Life and our Elanco Healthy Purpose™ Sustainability/ESG Pledges - all to advance the health of animals, people and the planet.
本社所在地 877 352-6261
代表者氏名 R. David Hoover
代表者役職名 Chairman of the Board
電話番号
設立年月日 43221
市場名 NYSE(ニューヨーク証券取引所)
ipoyear
従業員数 5880人
url www.elanco.com
nasdaq_url
adr_tso
EBITDA EBITDA(百万ドル) 609.80000
終値(lastsale)
時価総額(marketcap)
時価総額 時価総額(百万ドル) 11726.20000
売上高 売上高(百万ドル) 3066.80000
企業価値(EV) 企業価値(EV)(百万ドル) 13723.70000
当期純利益 当期純利益(百万ドル) 86.50000
決算概要 決算概要 BRIEF: For the fiscal year ended 31 December 2018 Elanco Animal Health Inc revenues increased 6% to $3.07B. Net income before extraordinary items totaled $86.5M vs. loss of $343.8M. Revenues reflect United States segment increase of 8% to $1.48B International segment increase of 4% to $1.58B. Net Income reflects Severance and other decrease of 90% to $15.5M (expense) Integration decrease of 71% to $26.5M (expense).

 ELANのテクニカル分析


 ELANのニュース

   Veterinary Healthcare Market to Witness Huge Growth by 2028 : Zoetis, Ceva, Virbac  2022/07/25 18:07:00 SBWire
Veterinary Healthcare Market 2022-2028 New Jersey, NJ -- ( SBWIRE ) -- 07/25/2022 -- The Latest research study released by HTF MI "Veterinary Healthcare Market" with 100+ pages of analysis on business Strategy taken up by key and emerging industry players and delivers know how of the current market development, landscape, technologies, drivers, opportunities, market viewpoint and status. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Some of the Major Companies covered in this Research are Boehringer Ingelheim, Zoetis, Elanco Animal Health, Bayer Animal Health, Merck Animal Health, Virbac, Dechra Veterinary Products, Ceva, Vetoquinol, Meiji, Ouro Fino Saude, Animalcare Group & Parnell etc. Click here for free sample + related graphs of the report @: https://www.htfmarketreport.com/sample-report/3703959-veterinary-healthcare-market-1 Browse market information, tables and figures extent in-depth TOC on "Veterinary Healthcare Market by Application (Companion Animals & Livestock Animals), by Product Type (, Medicines, Vaccine & Other), Business scope, Manufacturing and Outlook – Estimate to 2027". for more information or any query mail at sales@htfmarketreport.com At last, all parts of the Veterinary Healthcare Market are quantitatively also subjectively valued to think about the Global just as regional market equally.
   IDEXX upgraded, Elanco downgraded as Goldman shakes up animal health coverage  2022/07/21 13:48:59 Seeking Alpha
Goldman Sachs has upgraded IDEXX Laboratories (IDXX) and downgraded Elanco Animal Health (ELAN) as the analysts led by Nathan Rich updated their coverage on animal healthcare industry in…
   Goldman Sachs Downgrades Elanco Animal Health to Sell  2022/07/21 07:44:04 Investing.com
https://www.investing.com/news/pro/goldman-sachs-downgrades-elanco-animal-health-to-sell-432SI-2850284
   Elanco Confirms Date and Conference Call for Second Quarter 2022 Financial Results Announcement  2022/07/18 10:30:00 Wallstreet:Online
Elanco Animal Health Incorporated (NYSE: ELAN) will announce its second quarter 2022 financial results on Monday, August 8, 2022. Elanco will also conduct a conference call on that day with the investment community and media to further detail the company’s performance. The conference call will begin at 8:00 a.m. eastern time. Investors, media, and the general public can access a live webcast
   The 3 Best Pet Stocks to Buy Now  2022/07/04 15:00:31 InvestorPlace
During the pandemic, many Americans got pets to keep them company when the lockdowns forced people to stay at home. Surveys and common sense indicate that most people will keep their new pets. With pets having become an integral part of millions of more American families, many companies are benefiting financially. Investors can hop on that trend by buying the best pet stocks. As someone who works from home, doesn’t have children, and has two pets, I can attest that pets can certainly help fill the social void caused by a lack of physically present co-workers and children. I can also tell you that pets can be somewhat costly. All together, the food, health care, health insurance, grooming, and pet sitting services my wife and I purchase for our dog, Dallas, and our cat, Strawberry, are far from cheap. So, companies are making a great deal of money from us and from the millions of other pet owners out there. 7 Warren Buffett Stocks to Buy and Hold for the Next Decade Three of the best pet stocks to buy benefit from Americans’ increased spending on their pets.
   Veterinary Healthcare Market to Witness Huge Growth by 2028 : Zoetis, Ceva, Virbac  2022/07/25 18:07:00 SBWire
Veterinary Healthcare Market 2022-2028 New Jersey, NJ -- ( SBWIRE ) -- 07/25/2022 -- The Latest research study released by HTF MI "Veterinary Healthcare Market" with 100+ pages of analysis on business Strategy taken up by key and emerging industry players and delivers know how of the current market development, landscape, technologies, drivers, opportunities, market viewpoint and status. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Some of the Major Companies covered in this Research are Boehringer Ingelheim, Zoetis, Elanco Animal Health, Bayer Animal Health, Merck Animal Health, Virbac, Dechra Veterinary Products, Ceva, Vetoquinol, Meiji, Ouro Fino Saude, Animalcare Group & Parnell etc. Click here for free sample + related graphs of the report @: https://www.htfmarketreport.com/sample-report/3703959-veterinary-healthcare-market-1 Browse market information, tables and figures extent in-depth TOC on "Veterinary Healthcare Market by Application (Companion Animals & Livestock Animals), by Product Type (, Medicines, Vaccine & Other), Business scope, Manufacturing and Outlook – Estimate to 2027". for more information or any query mail at sales@htfmarketreport.com At last, all parts of the Veterinary Healthcare Market are quantitatively also subjectively valued to think about the Global just as regional market equally.
   IDEXX upgraded, Elanco downgraded as Goldman shakes up animal health coverage  2022/07/21 13:48:59 Seeking Alpha
Goldman Sachs has upgraded IDEXX Laboratories (IDXX) and downgraded Elanco Animal Health (ELAN) as the analysts led by Nathan Rich updated their coverage on animal healthcare industry in…
   Goldman Sachs Downgrades Elanco Animal Health to Sell  2022/07/21 07:44:04 Investing.com
https://www.investing.com/news/pro/goldman-sachs-downgrades-elanco-animal-health-to-sell-432SI-2850284
   Elanco Confirms Date and Conference Call for Second Quarter 2022 Financial Results Announcement  2022/07/18 10:30:00 Wallstreet:Online
Elanco Animal Health Incorporated (NYSE: ELAN) will announce its second quarter 2022 financial results on Monday, August 8, 2022. Elanco will also conduct a conference call on that day with the investment community and media to further detail the company’s performance. The conference call will begin at 8:00 a.m. eastern time. Investors, media, and the general public can access a live webcast
   The 3 Best Pet Stocks to Buy Now  2022/07/04 15:00:31 InvestorPlace
During the pandemic, many Americans got pets to keep them company when the lockdowns forced people to stay at home. Surveys and common sense indicate that most people will keep their new pets. With pets having become an integral part of millions of more American families, many companies are benefiting financially. Investors can hop on that trend by buying the best pet stocks. As someone who works from home, doesn’t have children, and has two pets, I can attest that pets can certainly help fill the social void caused by a lack of physically present co-workers and children. I can also tell you that pets can be somewhat costly. All together, the food, health care, health insurance, grooming, and pet sitting services my wife and I purchase for our dog, Dallas, and our cat, Strawberry, are far from cheap. So, companies are making a great deal of money from us and from the millions of other pet owners out there. 7 Warren Buffett Stocks to Buy and Hold for the Next Decade Three of the best pet stocks to buy benefit from Americans’ increased spending on their pets.
   Veterinary Healthcare 2022 Global Market Outlook, Research, Trends and Forecast to 2028  2022/05/26 12:49:00 SBWire
Global Veterinary Healthcare Market is valued approximately USD 49119.8 Million in 2021 and is anticipated to grow with a healthy growth rate of more than 7.31% over the forecast period 2022-2028. London, UK -- ( SBWIRE ) -- 05/26/2022 -- A New Market Research Study on "Global Veterinary Healthcare Size & Growth Analysis Report 2022-2028" added on intelligencemarketreport.com with the latest market size, share, trends and regional analysis. Veterinary Healthcare offers treatment for both small and large animals with experienced and professional vet services. The major factors driving the growth for the market are increasing prevalence of zoonotic diseases. For instance, according to the World Health Organization (WHO), there are currently over 200 prevailing zoonosis diseases around the world, including new and existing diseases, as of 2020. According to a UN Food and Agriculture Organization report, the majority of human diseases are spread by animals. Along with this, increasing initiatives by governments and animal welfare associations globally.
   Elanco Animal Health Incorporated (ELAN) CEO Jeffrey Simmons on Q1 2022 Results - Earnings Call Transcript  2022/05/09 16:53:07 Seeking Alpha
Elanco Animal Health Incorporated (NYSE:NYSE:ELAN) Q1 2022 Earnings Conference Call May 9, 2022, 08:00 AM ET Company Participants Katy Grissom - Head of IR Jeffrey Simmons - CEO Todd Young…
   Elanco Animal Health Cuts FY22 Guidance After Q1 Earnings Beat Expectations Marginally  2022/05/09 14:35:57 Benzinga
Elanco Animal Health Inc (NYSE: ELAN ) has reported a Q1 EPS of $0.36 , lower than the $0.37 reported a year ago, surpassing analysts'' view of $0.35. Revenue was $1.225 billion, a decrease of 1% YY, slightly above the consensus of $1.22 billion. Pet Health''s revenue decreased by 1% and was up 2% when excluding the unfavorable impact of foreign exchange rates. Growth in Seresto, Credelio franchise, and … Full story available on Benzinga.com
   Elanco Animal Health slips following updated lowered guidance (NYSE:ELAN)  2022/05/09 14:26:04 Seeking Alpha
Shares of Elanco Animal Health (ELAN) are down 5% in Monday morning trading after the company issued updated 2022 guidance including revenue below expectations.
   Elanco Animal Health Incorporated 2022 Q1 - Results - Earnings Call Presentation (NYSE:ELAN)  2022/05/09 13:56:14 Seeking Alpha
The following slide deck was published by Elanco Animal Health Incorporated in conjunction with their 2022 Q1 earnings call.

 関連キーワード  (医薬品 米国株 ELAN エランコ・アニマル・ヘルス ELAN )

 twitter  (公式ツイッターやCEOツイッターなど)